ExecPay

RA Session II

Overview202220212020

Overview

RA Session II received an average of $4M in total compensation, including $481K in salary, at Taysha Gene Therapies from 2020 to 2022.

Source: SEC filings on May 8, 2023 and April 28, 2022.
Session's 2022 pay

Related executives

We found four more executives who work or worked at Taysha Gene Therapies.

Sean Nolan

Taysha Gene Therapies

Chief Executive Officer

2

Sukumar Nagendran

Taysha Gene Therapies

President and Head of Research and Development

2

Kamran Alam

Taysha Gene Therapies

Chief Financial Officer

4

Suyash FFPM

Taysha Gene Therapies

Chief Medical Officer

2

News

You may also like

Taysha Gene Therapies